Direct effects of neuroleptics on the activity of CYP2A in the liver of rats

Pharmacological Reports

Volumn 57, Issue 6, 2005, Pages 867-871

  Haduch, Anna ^a   Wójcikowski, Jacek ^a   Daniel, Władysława A ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Chronic treatment; CYP2A; Haloperidol; In vitro study; Liver microsomes; Phenothiazines; Rat; Risperidone; Sertindole; Testosterone 7 hydroxylation

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CHLORPROMAZINE; CYTOCHROME P450 2A; CYTOCHROME P450 2C11; CYTOCHROME P450 3A; HALOPERIDOL; LEVOMEPROMAZINE; NEUROLEPTIC AGENT; PERAZINE; PHENOTHIAZINE DERIVATIVE; PROMAZINE; RISPERIDONE; SERTINDOLE; TESTOSTERONE; THIORIDAZINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; ENZYME ACTIVITY; HYDROXYLATION; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; LIVER; LIVER MICROSOME; MALE; NONHUMAN; RAT; STATISTICAL ANALYSIS; TESTOSTERONE METABOLISM;

EID: 33645674436     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Arlotto MP, Trant JM, Estabrook RW: Measurement of steroid hydroxylation reactions by high-performance liquid chromatography as indicator of P450 identity and function. In: Methods in Enzymology. Ed. Waterman MR, Johnson EF, Academic Press Inc., Harcourt Brace Jovanovich, Publishers, San Diego, California, USA, 1991, vol. 206, 454-462.
2. Daniel WA: The influence of long-term treatment with psychotropic drugs on cytochrome P450: the involvement of different mechanisms. Expert Opin Drug Metab Toxicol, 2005, 1, 203-217.
3. Daniel WA, Haduch A, Wójcikowski J: Inhibition of rat liver CYP2D in vitro and after 1-day and long-term exposure to neuroleptics in vivo - possible involvement of different mechanisms. Eur Neuropsychopharmacol, 2005, 15, 103-110.
4. Guengerich FP: Comparisons of catalytic selectivity of cytochrome P450 subfamily enzymes from different species. Chem-Biol Interactions, 1997, 106, 161-182.
5. Honkakoski P, Negishi M: Regulation of cytochrome P450 (CYP) genes by nuclear receptors. Biochem J, 2000, 347, 321-337.
6. Honkakoski P, Negishi M: The structure, function and regulation of cytochrome P450 2A enzymes. Drug Metab Rev, 1997, 29, 977-996.
7. Mugford CA, Kedderis GL: Sex-dependent metabolism of xenobiotics. Drug Metab Rev, 1998, 30, 441-498.
8. Rane A, Liu Z, Level R, Bjelfman C, Thys C, Ericson H, Hansson et al.: Differential effects of neuroleptic agents on hepatic cytochrome P-450 isoenzymes in the male rat. Biochim Biophys Acta, 1996, 1291, 60-66.
9. Ryan DE, Levin W: Purification and characterization of hepatic microsomal cytochrome P-450. Pharmacol Ther, 1990, 45, 153-239.
10. Sonderfan AJ, Arlotto MP, Dutton DR, McMillen SK, Parkinson A: Regulation of testosterone hydroxylation by rat liver microsomal cytochrome P-450. Arch Biochem Biophys, 1987, 255, 27-41.
11. Su T, Ding X: Regulation of the cytochrome P450 2A genes. Toxicol Appl Pharmacol, 2004, 199, 285-294.